BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 4710467)

  • 1. [Biguanide derivative monotherapy in diabetes].
    Rojszykowa E
    Pol Tyg Lek; 1973 May; 28(19):694-6. PubMed ID: 4710467
    [No Abstract]   [Full Text] [Related]  

  • 2. [Biguanide treatment of diabetics. Effect on body weight--tolerance].
    Klein W; Hole P; Dietzmann HB; Buding A
    Munch Med Wochenschr; 1969 Nov; 111(48):2507-10. PubMed ID: 5396030
    [No Abstract]   [Full Text] [Related]  

  • 3. [Diabetes mellitus and obesity: monotherapy using biguanides].
    Bäbler M
    Schweiz Med Wochenschr; 1973 Apr; 103(17):641-5. PubMed ID: 4704806
    [No Abstract]   [Full Text] [Related]  

  • 4. [Results of diabetes therapy with Silubin retard].
    Kopp H
    Med Klin; 1966 Apr; 61(15):592-6. PubMed ID: 4869026
    [No Abstract]   [Full Text] [Related]  

  • 5. [A new derivative of the biguanide series. Its role in the treatment of diabetes].
    Journ Annu Diabetol Hotel Dieu; 1976 May; ():341-4. PubMed ID: 1011423
    [No Abstract]   [Full Text] [Related]  

  • 6. [Silubin retard--long-term effects].
    Dub O; Brozek I; Pátek F
    Cas Lek Cesk; 1971 Jun; 110(25):591-4. PubMed ID: 5088225
    [No Abstract]   [Full Text] [Related]  

  • 7. [On the clinical use of biguanides].
    Haese E
    Arzneimittelforschung; 1969 Apr; 19(4):633-8. PubMed ID: 5819164
    [No Abstract]   [Full Text] [Related]  

  • 8. [On the therapy of diabetes mellitus with biguanides].
    Riess PJ; Saum R
    Med Klin; 1968 May; 63(19):764-7. PubMed ID: 5730198
    [No Abstract]   [Full Text] [Related]  

  • 9. [The relationship between biguanide therapy and lactic acidosis in diabetes mellitus].
    György V; Ida M; Sándor N
    Orv Hetil; 1977 Sep; 118(38):2263-7. PubMed ID: 412157
    [No Abstract]   [Full Text] [Related]  

  • 10. [The effect of biguanide preparations on lipid metabolism].
    Pavlov K
    Vutr Boles; 1974; 13(6):115-8. PubMed ID: 4467468
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Activity of the pancreas glycogenase under oral biguanide and tolbutamide loading in diabetes].
    Schilling I; Jutzi E
    Dtsch Z Verdau Stoffwechselkr; 1967 Feb; 26(4):180-5. PubMed ID: 5595284
    [No Abstract]   [Full Text] [Related]  

  • 12. [Study of a new delayed-action biguanide].
    Plauchu M; Pousset G; Chapuy H; Amourdedieu J; Tuaillon J
    Lyon Med; 1969 Oct; 222(35):467-76. PubMed ID: 5401952
    [No Abstract]   [Full Text] [Related]  

  • 13. [Follow-up of a group of diabetics during a long-term administration of the depot form of the preparation n-butyl-biguanide (Solubin-retard Grünenthal)].
    Popović D; Skrabalo Z; Papić Z
    Lijec Vjesn; 1971; 93(11):1233-41. PubMed ID: 5161499
    [No Abstract]   [Full Text] [Related]  

  • 14. [Long term monotherapy with biguanides in diabetes (author's transl)].
    Studer-Wobmann E
    Schweiz Rundsch Med Prax; 1974 Nov; 63(44):1316-7. PubMed ID: 4438250
    [No Abstract]   [Full Text] [Related]  

  • 15. [Effect of N,N-dimethyl-biguanide on certain elements of the lipid metabolism in diabetics].
    Orlikowska W
    Pol Tyg Lek; 1966 Nov; 21(47):1812-5. PubMed ID: 5979520
    [No Abstract]   [Full Text] [Related]  

  • 16. [The effect of biguanides on insulin sensitivity of maturity onset diabetics (author's transl)].
    Lisch HJ; Sailer S; Braunsteiner H
    Wien Klin Wochenschr; 1980 Apr; 92(8):266-9. PubMed ID: 6996339
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A hypoglycemizing sulfamide associated with biguanide in the treatment of type I diabetes in adults].
    Plauchu M; Thevenon P
    Lyon Med; 1968 Oct; 220(42):953-63. PubMed ID: 5742623
    [No Abstract]   [Full Text] [Related]  

  • 18. [The influence of clofibrate on elevated serum lactate levels in diabetic patients treated with biguanides (author's transl)].
    Vogelberg KH; Cicmir I; Heggen ME
    Arzneimittelforschung; 1980; 30(4):683-5. PubMed ID: 7190412
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Treatment of diabetics by biguanide--its applicability with special reference to clinical observations].
    Takeda M; Nishikawa K; Miki S; Fujii Y; Tatsumi K
    Nihon Naibunpi Gakkai Zasshi; 1968 Oct; 44(7):794-805. PubMed ID: 5752684
    [No Abstract]   [Full Text] [Related]  

  • 20. [Indications and contraindications to the diabetes mellitus therapy by biguanide derivatives in the light of the metabolic and epidemiologic studies (author's transl)].
    Tatoń J; Kowalik-Borówka E
    Przegl Lek; 1979; 36(7):553-7. PubMed ID: 504704
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.